Novel compounds of the formula I ##STR00001## in which D, W, X, Y, T and R.sup.1 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.